Targeting Senescence Specific Mechanisms of NF-κB Activation to Reverse Chronic Pulmonary Fibrosis
Description: PROJECT NARRATIVE The current study seeks to investigate the mechanisms whereby a specific type of lung cell associated with idiopathic pulmonary fibrosis (IPF) accumulates and drives the pathology of this disease. To accomplish this, we have developed a new compound that selectively blocks the activation of a pathway that maintains these cells in the lung. Using cell-culture, and rodent models of IPF we will further test this pathway and assess how well this new compound could potentially treat IPF.
Funding type: research
Funder scheme: R01
Start date: 2024-05-01
End date: 2029-02-28
Investigator: ANDREW JON HAAK (lead)
Institutions: Mayo Clinic, MAYO CLINIC ROCHESTER
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Funded outputs count: 3
Funder award ID: R01HL167796
OpenAlex ID: G9000886107
